Latest filing published 04 Jun 2025 for Taysha Gene Therapies, Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Laura Sepp-Lorenzino: trading record in brief
Laura Sepp-Lorenzino is a declared insider at 2 companies (senior executive); the most frequent names are Intellia Therapeutics, Inc. and Taysha Gene Therapies, Inc. Between 4 August 2021 and 2 June 2025, the trades on record add up to 36 filings.
Sales make up the whole of the open-market record (24 sales, €16.4M). Outside the open market, there are 5 share grants and 7 option exercises. In 2025 alone, the filings show no purchases and 1 sale.
The record was last updated on 4 June 2025 with a share grant in Taysha Gene Therapies, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Laura Sepp-Lorenzino
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 56,623 shares0Common StockSEC:0001415889-25-015571:0
- 8,966 shares@ US$12.186.7% of flowCommon StockSEC:0000950170-25-003002:0
- 3,500 sharesCommon StockSEC:0000950170-25-001232:0
- 49,220 shares0Common StockSEC:0001415889-24-015038:0
- 37,966 shares0Common StockSEC:0000950170-24-025907:0
- 1,608 shares@ US$28.662.7% of flowCommon StockSEC:0000950170-24-003632:0
- 5,532 shares@ US$29.469.4% of flowCommon StockSEC:0000950170-24-002514:0
- 3,500 sharesCommon StockSEC:0000950170-24-001210:0
- 29,938 shares0Common StockSEC:0001209191-23-015742:0
- 2,508 shares@ US$37.215.6% of flowCommon StockSEC:0001209191-23-002433:0
- 3,500 sharesCommon StockSEC:0001209191-23-001498:0
- 3,500 sharesCommon StockSEC:0001209191-22-015976:0
- 27,000 shares@ US$13.4031.1% of flowCommon StockSEC:0001209191-21-054321:0
- 26,000 shares@ US$13.4029.8% of flowCommon StockSEC:0001209191-21-050228:0
14 of 14 declarations
